Vaxxinity Other Current Liabilities

Vaxxinity posts a other current liabilities of $14M as of December 2023. That compares with $24M in the prior-year period — down 42.4% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Vaxxinity's other current liabilities was $24M. The latest reading is $14M — a 42.4% year-over-year decrease (period ending December 2023). Use the history and growth charts on this page for a longer lookback.

Other Current Liabilities is one piece of Vaxxinity's financial statement story. At $14M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for VAXX's other current liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Vaxxinity's other metric pages and overview cover the third.